MSH|^~\&|LAB|LMH|||202001071150||ORU^R01|4140781|D|2.3|||AL|NE
PID|1||LM00005473|LM5306|LUMEDTEST^TEST^EMERG||19880608|F||||||||||LM000642/19|9874826735
OBR|1|37543^LAB|00028241^0701:C00004R^LAB^070120:C4^37543|500.1000^CP7^Chem 7 - Glu R,Urea,Crea,Lytes^^^XXX-1710||202001071149|202001070700|||||||202001071148||||||||||LAB|F||||
OBX|1|ST|500.1900^NA^Sodium^^2951-2^2951-2|1|138^^Y|mmol/L|135-145|N||A^S|F|||202001071150
OBX|2|ST|500.2000^K^Potassium^^2823-3^2823-3|1|5.1^^Y|mmol/L|3.5-5.0|H||A^S|F|||202001071150
OBX|3|ST|500.2100^CL^Chloride^^2075-0^2075-0|1|97^^Y|mmol/L|98-108|L||A^S|F|||202001071150
OBX|4|ST|500.2200^BICARB^Bicarbonate^^1962-0^1962-0|1|20^^Y|mmol/L|20-30|N||A^S|F|||202001071150
OBX|5|ST|500.2300^GAP^Anion Gap^^33037-3^33037-3|1|21^^Y|mmol/L|3-16|H||A^S|F|||202001071150
OBX|6|ST|500.2400^UREA^Urea^^14937-7^22664-7|1|10^^Y|mmol/L|2-9|H||A^S|F|||202001071150
OBX|7|ST|500.2600^CR^Creatinine Modified Jaffe^^14682-9^14682-9|1|105^^Y|umol/L|45-90|H||A^S|F|||202001071150
OBX|8|ST|500.2700^EGFR^Glomerular Filtration Rate Est^^33914-3^33914-3|1|61^^Y|mL/min|>60|N||A^S|F|||202001071150
OBX|9|ST|500.2900^GLU^Glucose, Random^^14749-6^14749-6|1|15.0^^Y|mmol/L|3.6-7.8|H||A^S|F|||202001071150
OBR|2|37543^LAB|00028241^0701:C00004R^LAB^070120:C4^37543|500.5690^TROP^Troponin I^^^10839-9||202001071149|202001070700|||||||202001071148||||||||||LAB|F||||
OBX|1|ST|500.5695^TROPIHS^Troponin I High Sensitivity^^89579-7^89579-7|1|3^^Y|ng/L|<18|N||A^S|F|||202001071150
NTE|1||Detectable Troponin I present. To assess the risk of acute
NTE|2||myocardial injury, consider repeat Troponin I in 3 hours to
NTE|3||evaluate the change ("delta"). If this is a follow up
NTE|4||Troponin I collected within 3-6 hours of previous:
NTE|5||Delta < 11 ng/L: Acute myocardial injury is unlikely.
NTE|6||Delta 11 - 21 ng/L: Consistent with myocardial injury, but
NTE|7||low positive predictive value for an acute event. Consider a
NTE|8||further Troponin I in another 3 hours to re-evaluate.
NTE|9||Delta >= 22 ng/L: Critical change in Troponin I. Result is
NTE|10||highly predictive for acute myocardial injury.
OBR|3|37543^LAB|00028241^0701:C00004R^LAB^070120:C4^37543|500.5800^CK^Creatine Kinase^^2157-6^2157-6||202001071149|202001070700|||||||202001071148||||||||||LAB|F||||
OBX|1|ST|500.5800^CK^Creatine Kinase^^2157-6^2157-6|1|145^^Y|U/L|<140|H||A^S|F|||202001071150
OBR|4|37543^LAB|00028241^0701:C00004R^LAB^070120:C4^37543|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7||202001071149|202001070700|||||||202001071148||||||||||LAB|F||||
OBX|1|ST|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7|1|9.0^^Y|mg/L|<7.5|H||A^S|F|||202001071150
NTE|1||This high sensitivity CRP method is sensitive to 0.3 mg/L
NTE|2||and is suitable for coronary artery risk assessment:
NTE|3||                         Less than 1.0 mg/L  low risk;
NTE|4||                         1.0 - 3.0 mg/L  intermediate risk;
NTE|5||                         Greater than 3.0 mg/L  high risk.
NTE|6||Values greater than 7.5 mg/L are significant for active
NTE|7||inflammation or infection and require follow up as
NTE|8||clinically needed. For consultation on specific patient
NTE|9||cases call your site Medical Biochemist. Interpretation
NTE|10||should be based on full history and other risk assessment
NTE|11||factors.